Tenaya Therapeutics, Inc. — Director's Dealing 2021

Aug 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tenaya Therapeutics, Inc. (TNYA)
CIK: 0001858848
Period of Report: 2021-08-03

Reporting Person: COLUMN GROUP III GP, LP (10% Owner)
Reporting Person: COLUMN GROUP III, LP (10% Owner)
Reporting Person: COLUMN GROUP III-A, LP (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-03	Common Stock	C	4389282	$0.00	Acquired	4414720	Indirect
2021-08-03	Common Stock	C	4956842	$0.00	Acquired	4985570	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-03	Series A Preferred Stock	$0.00	C	3727742	Disposed		Common Stock (3727742)	Indirect
2021-08-03	Series A Preferred Stock	$0.00	C	4209755	Disposed		Common Stock (4209755)	Indirect
2021-08-03	Series B Preferred Stock	$0.00	C	472659	Disposed		Common Stock (472659)	Indirect
2021-08-03	Series B Preferred Stock	$0.00	C	533781	Disposed		Common Stock (533781)	Indirect
2021-08-03	Series C Preferred Stock	$0.00	C	188881	Disposed		Common Stock (188881)	Indirect
2021-08-03	Series C Preferred Stock	$0.00	C	213306	Disposed		Common Stock (213306)	Indirect

Footnotes

F1: The securities are directly held by The Column Group III, LP ("TCG III LP"). The Column Group III GP, LP ("TCG III GP") is the general partner of TCG III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are David Goeddel, a member of the Issuer's board of directors, Peter Svennilson and Tim Kutzkey (collectively, the "Managing Partners"). The Managing Partners may be deemed to share voting and investment power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.

F2: The securities are directly held by The Column Group III-A, LP ("TCG III-A LP"). TCG III GP is the general partner of TCG III-A LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are the Managing Partners. The Managing Partners may be deemed to share voting and investment power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.

F3: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock will automatically convert into one share of common stock immediately prior to the completion of the Issuer's initial public offering, and has no expiration date.